Options for preserving fertility in women undergoing gonadotoxic treatment.
Level V
Where this comes from
- Record sourced from PubMed, PMID 34728486.
- Also identified by DOI 10.3949/ccjm.88gr.21001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cancer chemotherapy and radiotherapy can be toxic to the ovaries, but women can improve their chances of preserving their fertility. Three options are available: gonadotropin-releasing hormone (GnRH) analogues, oocyte cryopreservation, and ovarian tissue cryopreservation. A fourth option, ovarian transposition, is valid for patients undergoing pelvic radiation but is not useful in patients undergoing chemotherapy.
Medical subject headings
- Antineoplastic Agents
- Fertility Preservation
- Neoplasms